2030년까지 아시아 태평양 근육감소증 치료 시장 예측 - 지역 분석 - 치료 유형(비타민 D 및 칼슘 보충제, 단백질 보충제, 비타민 B12 보충제 등) 및 유통 채널(약국, 소매 채널, 온라인 채널 및 기타)별
임상 시험 단계의 제품이 아시아 태평양 근육감소증 치료 시장을 주도합니다.
근육감소증 치료 시장에서 활동하는 몇몇 주요 업체가 점점 더 성장하고 있습니다. 근육감소증 치료제 개발에 주력하고 있다. 새로운 근육감소증 치료법은 현재 개발 중이며 임상 시험에서 테스트되고 있습니다. 이러한 제품 중 몇 가지가 아래에 언급되어 있습니다.
표 1. 임상 개발 중인 근육감소증 약물
회사 이름 개입 조건 임상 시험 단계
AN777을 함유한 Abbott Nutrition 의료 식품
경구 영양제 영양실조
Sarcopenia PHASE3
Nutricia Research 식이 보조제: Bolus ONS A
식이 보조제: Bolus ONS B
식이 보조제 : Bolus ONS C
식이 보조제: Bolus ONS D 근육감소증 PHASE1
Novartis Pharmaceuticals 약물: Bimagrumab 근육감소증 PHASE2
McMaster University 행동: 단계 감소 근육감소증 PHASE1
Metabolic Technologies Inc. 식이 보충제: 위약
약물: HMB Plus 비타민 D
행동: 비운동
행동: 운동 근육감소증 PHASE1
머크 Sharp & Dohme LLC 약품: 대조약 MK-077
약물: 대조약 위약 근육감소증 PHASE2
Immunotec Inc. 식이보충제: 면역
식이보충제: 카세인 노화 및 근육감소증 PHASE2
br>
양리준 복합제: 3개월 집중 중재 근육감소증 PHASE4
Regeneron Pharmaceuticals 의약품: REGN1033(SAR391786)
의약품: 위약 근육감소증 PHASE2
출처: 회사 웹사이트 및 Insight 파트너 분석
따라서 다양한 임상 개발 단계에 있는 약물의 파이프라인 확장은 근육감소증 치료 시장 성장을 위한 중요한 기회를 제공합니다.
아시아 태평양 근육감소증 치료 시장 개요
아시아 태평양 근육감소증 치료 시장은 중국, 인도, 일본, 한국, 호주 및 기타 아시아 태평양 지역으로 분류됩니다. 아시아 태평양 지역은 예측 기간 동안 글로벌 시장에서 가장 빠른 CAGR을 기록할 것으로 예상됩니다. 아시아는 인구 노령화가 빠르게 진행되는 세계에서 가장 인구가 많은 대륙이며, 근육감소증 관련 문제는 여러 아시아 국가에서 점점 더 널리 퍼지고 있습니다. 아시아인은 서구인과 매우 다른 생활방식을 갖고 있으며 다른 식습관을 따릅니다. 아시아에서는 노인의 근육감소증이 여성(유병률 7.7~21.8%)보다 남성(유병률 9.6~22.1%)에서 더 흔합니다. 근육감소증에 대한 아시아 실무 그룹(AWGS)은 아시아에서 근육감소증 연구를 촉진하는 것을 목표로 합니다.
2030년까지 아시아 태평양 근육감소증 치료 시장 수익 및 예측(미화 백만 달러)
아시아 태평양 근육감소증 치료 시장 세분화
아시아 태평양 근육감소증 치료 시장은 치료 유형으로 분류됩니다. , 유통 채널 및 국가.
치료 유형에 따라 아시아 태평양 근육감소증 치료 시장은 비타민 D 및 칼슘 보충제, 단백질 보충제, 비타민 B12 보충제 등으로 분류됩니다. 비타민 D 및 칼슘 보충제 부문은 2022년 아시아 태평양 근육감소증 치료 시장에서 가장 큰 점유율을 차지했습니다.
유통 채널 측면에서 아시아 태평양 근육감소증 치료 시장은 약국, 소매 채널, 온라인 채널 등으로 분류됩니다. . 약국 부문은 2022년에 가장 큰 아시아 태평양 근육감소증 치료 시장 점유율을 차지했습니다.
국가별로 아시아 태평양 근육감소증 치료 시장은 중국, 인도, 일본, 호주, 한국 및 기타 아시아 태평양 지역으로 분류됩니다. . 중국은 2022년 아시아 태평양 근육감소증 치료 시장 점유율을 장악했습니다.
Abbott Laboratories, Bayer AG, Metagenics LLC, Nestle Health Science SA, Novartis AG, Pfizer Inc, Sanofi SA, Amway Corp 및 GSK Plc는 그 중 일부입니다. 아시아 태평양 근육감소증 치료 시장의 주요 기업
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Sarcopenia Treatment Market - Key Industry Dynamics
4.1 Asia Pacific Sarcopenia Treatment Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Upsurge in Geriatric Population
4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
4.3 Key Market Restraints:
4.3.1 Unavailability of Direct Interventions
4.4 Key Market Opportunities:
4.4.1 Products in Clinical Trial Phases
4.5 Future Trends:
4.5.1 Rising Awareness About Sarcopenia
4.6 Impact of Drivers and Restraints:
5. Sarcopenia Treatment Market - Asia Pacific Market Analysis
5.1 Asia Pacific Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
5.2 Asia Pacific Sarcopenia Treatment Market Forecast and Analysis
6. Asia Pacific Sarcopenia Treatment Market Analysis - By Treatment Type
6.1 Vitamin D and Calcium Supplement
6.1.1 Overview
6.1.2 Vitamin D and Calcium Supplement: Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.2 Protein Supplement
6.2.1 Overview
6.2.2 Protein Supplement : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Vitamin B12 Supplement
6.3.1 Overview
6.3.2 Vitamin B12 Supplement: Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Sarcopenia Treatment Market Analysis - By Distribution Channel
7.1 Pharmacies
7.1.1 Overview
7.1.2 Pharmacies : Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
7.2 Retail Channels
7.2.1 Overview
7.2.2 Retail Channels : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Online Channels
7.3.1 Overview
7.3.2 Online Channels : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others : Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Sarcopenia Treatment Market - Country Analysis
8.1 Asia Pacific
8.1.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.2 China Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.2.1 China Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.2.2 China Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.3 India Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.3.1 India Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.3.2 India Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.4 Japan Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.4.1 Japan Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.4.2 Japan Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.5 South Korea Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.5.1 South Korea Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.5.2 South Korea Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.6 Australia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.6.1 Australia Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.6.2 Australia Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.7 Rest of Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.7.1 Rest of Asia Pacific Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.7.2 Rest of Asia Pacific Sarcopenia Treatment Market Breakdown by Distribution Channel
9. Sarcopenia Treatment Market-Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Sarcopenia Treatment Market
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Bayer AG
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Metagenics LLC
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Nestle Health Science SA
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Novartis AG
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Pfizer Inc
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Sanofi SA
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Amway Corp
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 GSK Plc
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Asia Pacific Sarcopenia Treatment Market Segmentation
Table 2. Sarcopenia Drug Under Clinical Development
Table 3. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
Table 4. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
Table 5. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
Table 6. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
Table 7. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 8. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 9. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 10. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 11. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 12. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 13. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 14. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 15. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 16. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 17. Rest of Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 18. Rest of Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 19. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
Table 20. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
Table 21. Glossary of Terms, Sarcopenia Treatment Market
List of Figures
Figure 1. Asia Pacific Sarcopenia Treatment Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Asia Pacific Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
Figure 4. Asia Pacific Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
Figure 5. Vitamin D and Calcium Supplement: Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Protein Supplement : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Vitamin B12 Supplement: Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Others : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Asia Pacific Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
Figure 10. Pharmacies : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Retail Channels : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Online Channels : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 13. Others : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Asia Pacific Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
Figure 15. Asia Pacific Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 16. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 17. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 18. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 19. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 20. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 21. Rest of Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 22. Growth Strategies in the Sarcopenia Treatment Market
1. Abbott Laboratories
2. Bayer AG
3. Metagenics LLC
4. Nestle Health Science SA
5. Novartis AG
6. Pfizer Inc
7. Sanofi SA
8. Amway Corp
9. GSK Plc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific sarcopenia treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific sarcopenia treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.